A New York Times investigation reported that in early studies of lecanemab (Leqembi ... The overall rate of emergency room visits for older adults with Alzheimer's disease was 36.1 visits per 1,000 ...

But since the start of last year, two Alzheimer's treatments have been approved in the United States: Biogen's lecanemab and Eli Lilly's donanemab. They work by targeting the build-up of two proteins ...

An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...